GRAL News

Merck, Mirum, Incyte and Grail are in focus this week as investors await key FDA decisions and a regulatory review involving treatments for lung disease, a rare bone disorder and cancer detection.

On Wednesday, GRAIL (NASDAQ:GRAL) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive financial dataread more...

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire SUNNYVALE, Calif., Sept. 3, 2026 SUNNYVALE, Calif., Sept. 3, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission...

GRAIL to Present at Morgan Stanley's 24th Annual Global Healthcare Conference GRAIL to Present at Morgan Stanley's 24th Annual Global Healthcare Conference PR Newswire MENLO PARK, Calif., Aug. 31, 2026 MENLO PARK, Calif., Aug. 31, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare...

GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri Multi-Cancer Early Detection Test GRAIL Announces FDA Advisory Committee Meeting to Review Premarket Approval Application for the Galleri Multi-Cancer Early Detection Test PR Newswire MENLO PARK...

GRAIL Reports Second Quarter 2026 Financial Results GRAIL Reports Second Quarter 2026 Financial Results PR Newswire MENLO PARK, Calif., Aug. 5, 2026 Q2 Galleri Test Volume Increased 35% to More Than 61,000 Year-Over-Year, and Galleri Revenue Grew 24% to $42.6 Million Galleri Test Volume and Revenue...

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Grail, Inc. (Grail or the Company) (NASDAQ: GRAL) and reminds investors of the August 4, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed...

GRAL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in GRAIL, Inc. Securities Lawsuit - Contact The Gross Law Firm GRAL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in GRAIL, Inc. Securities Lawsuit - Contact The Gross Law Firm PR Newswire...

GRAL DEADLINE TODAY: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GRAL DEADLINE TODAY: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit PR Newswire SAN FRANCISCO, Aug. 4, 2026 SAN FRANCISCO, Aug. 4, 2026...